ロード中...
Innate T-αβ lymphocytes as new immunological components of anti-tumoral “off-target” effects of the tyrosine kinase inhibitor dasatinib
Kinase inhibitors hold great potential as targeted therapy against malignant cells. Among them, the tyrosine kinase inhibitor dasatinib is known for a number of clinically relevant off-target actions, attributed in part to effects on components of the immune system, especially conventional T-cells a...
保存先:
| 出版年: | Sci Rep |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7039999/ https://ncbi.nlm.nih.gov/pubmed/32094501 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-60195-z |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|